Your browser doesn't support javascript.
loading
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Butowski, Nicholas; Chang, Susan M; Lamborn, Kathleen R; Polley, Mei-Yin; Pieper, Russell; Costello, Joseph F; Vandenberg, Scott; Parvataneni, Rupa; Nicole, Angelina; Sneed, Patricia K; Clarke, Jennifer; Hsieh, Emily; Costa, Bruno M; Reis, Rui M; Hristova-Kazmierski, Maria; Nicol, Steven J; Thornton, Donald E; Prados, Michael D.
Affiliation
  • Butowski N; Neuro-Oncology Service, Department of Neurological Surgery, University of California, San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA. butowski@neurosurg.ucsf.edu
Neuro Oncol ; 13(12): 1331-8, 2011 Dec.
Article in En | MEDLINE | ID: mdl-21896554
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacogenetics / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gliosarcoma / Glioblastoma / DNA Methylation / Chemoradiotherapy Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Neuro Oncol Year: 2011 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacogenetics / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gliosarcoma / Glioblastoma / DNA Methylation / Chemoradiotherapy Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Neuro Oncol Year: 2011 Type: Article Affiliation country: United States